Related references
Note: Only part of the references are listed.A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: Activation of proteinase-activated receptor 1 and epidermal growth factor receptor
Lin Gao et al.
EXPERIMENTAL CELL RESEARCH (2010)
Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia
Robert S. Smith et al.
BIOLOGICAL CHEMISTRY (2008)
Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3 beta pathway
Yu-Yu Yao et al.
CARDIOVASCULAR RESEARCH (2008)
Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation
Makoto Hagiwara et al.
HUMAN GENE THERAPY (2008)
Tissue kallikrein elicits cardioprotection by direct kinin B2 receptor activation independent of kinin formation
Julie Chao et al.
HYPERTENSION (2008)
Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress
Bo Shen et al.
HYPERTENSION (2008)
Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction
Lin Gao et al.
LABORATORY INVESTIGATION (2008)
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion
Hang Yin et al.
LIFE SCIENCES (2008)
Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury
Grant Bledsoe et al.
TOXICOLOGICAL SCIENCES (2008)
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction
Yu-Yu Yao et al.
JOURNAL OF CARDIAC FAILURE (2007)
Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling
Hang Yin et al.
PEPTIDES (2007)
Tissue kallikrein infusion prevents cardiornyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction
Yu-Yu Yao et al.
REGULATORY PEPTIDES (2007)
Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity
Julie Chao et al.
HYPERTENSION (2007)
Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3 beta activation
Huey-Jiun Li et al.
CARDIOVASCULAR RESEARCH (2007)
Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling
Paolo Madeddu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation
Julie Chao et al.
HUMAN GENE THERAPY (2006)
Proteinase-activated receptors, targets for kallikrein signaling
Katerina Oikonomopoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more
Katerina Oikonomopoulou et al.
BIOLOGICAL CHEMISTRY (2006)
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
Julie Chao et al.
BIOLOGICAL CHEMISTRY (2006)
Experimental therapy with tissue kallikrein against cerebral ischemia
J Chao et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor
CF Xia et al.
HYPERTENSION (2006)
Kallikrein activates bradykinin B2 receptors in absence of kininogen
D Biyashev et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis
G Bledsoe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis
CF Xia et al.
HUMAN GENE THERAPY (2006)
Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents
S Houle et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Release of bradykinin and expression of kinin B2 receptors in the brain:: role for cell death and brain edema formation after focal cerebral ischemia in mice
M Gröger et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis
E Ackah et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats
D Montanari et al.
DIABETES (2005)
Kallikrein-kinin in stroke, cardiovascular and renal disease
J Chao et al.
EXPERIMENTAL PHYSIOLOGY (2005)
Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways
H Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The kallikrein-kinin system: Current and future pharmacological targets
ME Moreau et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Effects of a bradykinin B2 receptor antagonist on ischemia-reperfusion injury in a canine lung transplantation model
N Hashimoto et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis
CF Xia et al.
HYPERTENSION (2004)
Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer
C Emanueli et al.
CIRCULATION (2004)
Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries
T Wang et al.
GENE THERAPY (2004)
Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress
JJ Zhang et al.
KIDNEY INTERNATIONAL (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine modelof transient focal cerebral ischemia
DZ Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury
DG Souza et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells
S Miura et al.
HYPERTENSION (2003)
Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice
R Maestri et al.
HYPERTENSION (2003)
Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors
S Houle et al.
HYPERTENSION (2003)
Tissue kallikrein is synthesized and secreted by human vascular endothelial cells
K Yayama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells
H Kataoka et al.
BLOOD (2003)
Kallistatin is a new inhibitor of angiogenesis and tumor growth
RQ Miao et al.
BLOOD (2002)
Regulation of angiogenesis by glycogen synthase kinase-3β
HS Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction
J Agata et al.
HYPERTENSION (2002)
Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia
S Zausinger et al.
BRAIN RESEARCH (2002)
Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer
C Emanueli et al.
CIRCULATION (2002)
Targeting kinin B1 receptor for therapeutic neovascularization
C Emanueli et al.
CIRCULATION (2002)
Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells
D Thuringer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Kinin receptors in pain and inflammation
R Couture et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins
J Dedio et al.
BIOLOGICAL CHEMISTRY (2001)
The new human tissue kallikrein gene family: Structure, function, and association to disease
GM Yousef et al.
ENDOCRINE REVIEWS (2001)
Protease activated receptors: theme and variations
PJ O'Brien et al.
ONCOGENE (2001)
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice
P Meneton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Kallikrein and kinin receptor expression in inflammation and cancer
K Bhoola et al.
BIOLOGICAL CHEMISTRY (2001)
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
TJ Harvey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells
J Plendl et al.
BIOLOGICAL CHEMISTRY (2000)
Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle
C Emanueli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
GM Yousef et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Thrombin signalling and protease-activated receptors
SR Coughlin
NATURE (2000)
Share Paper
